Vertex Pharmaceuticals
VRTX
VRTX
704 hedge funds and large institutions have $40.2B invested in Vertex Pharmaceuticals in 2018 Q4 according to their latest regulatory filings, with 93 funds opening new positions, 233 increasing their positions, 264 reducing their positions, and 78 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
2% less call options, than puts
Call options by funds: $403M | Put options by funds: $412M
12% less repeat investments, than reductions
Existing positions increased: 233 | Existing positions reduced: 264
14% less capital invested
Capital invested by funds: $46.6B → $40.2B (-$6.44B)
Holders
704
Holding in Top 10
16
Calls
$403M
Puts
$412M
Top Buyers
| 1 | +$400M | |
| 2 | +$397M | |
| 3 | +$361M | |
| 4 |
Jennison Associates
New York
|
+$122M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$113M |
Top Sellers
| 1 | -$231M | |
| 2 | -$147M | |
| 3 | -$112M | |
| 4 |
Capital Research Global Investors
Los Angeles,
California
|
-$97.8M |
| 5 |
Prudential Financial
Newark,
New Jersey
|
-$95.6M |